Madrigal Pharmaceuticals, Inc. MDGL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s restricted cash?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported restricted cash of $5.16M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s restricted cash changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s restricted cash increased by 3.1% year-over-year, from $5M to $5.16M.
- What does restricted cash mean?
- Cash that is set aside for specific legal or contractual obligations and cannot be used for general business operations.
- How do you interpret restricted cash?
- An increase may signal new contractual obligations or collateral requirements, while a decrease indicates the release of previously restricted funds.
- How does restricted cash compare across companies?
- Common in companies with significant facility leases or ongoing regulatory compliance requirements.